“Fast tracking a vaccine trial in four weeks for safety, immunogenicity and efficacy is just not possible if things are to be done correctly,� Shahid Jameel, virologist and CEO of the Wellcome Trust/DBT India Alliance told PTI.
Scientists strike note of caution as #39;Made in India#39; vaccine programme gains momentum Â
“Fast tracking a vaccine trial in four weeks for safety, immunogenicity and efficacy is just not possible if things are to be done correctly,� Shahid Jameel, virologist and CEO of the Wellcome Trust/DBT India Alliance told PTI.
